Ananym Capital Builds Bio-Techne Stake, Urges Strategic Review Including Potential Sale
2026-06-15 12:41:08
Activist investor Ananym Capital Management has built a stake in Bio-Techne Corp. according to Bloomberg, and is pushing the board to conduct a strategic review that would include a potential sale.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
